$142.2 M

CRMD Mkt cap, 04-Dec-2018

$372.5 K

CorMedix Revenue Q3, 2018
CorMedix Gross profit (Q3, 2018)60.1 K
CorMedix Gross profit margin (Q3, 2018), %16.1%
CorMedix Net income (Q3, 2018)-10.2 M
CorMedix EBIT (Q3, 2018)-10.2 M
CorMedix Cash, 30-Sep-20186.4 M

CorMedix Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.0k189.3k210.1k224.1k329.3k

Revenue growth, %

9359%11%7%

Cost of goods sold

201.6k445.8k318.7k366.7k115.0k

Gross profit

(199.6k)(256.5k)(108.6k)(142.6k)214.4k

Gross profit Margin, %

(9975%)(136%)(52%)(64%)65%

R&D expense

1.1m1.2m6.3m15.7m24.5m

General and administrative expense

1.9m3.5m10.3m8.9m8.7m

Operating expense total

3.0m4.7m(16.5m)(24.6m)(33.1m)

EBIT

(3.0m)(4.9m)(8.9m)(16.7m)(24.8m)(32.9m)

EBIT margin, %

(245647%)(4703%)(7926%)(11049%)(9997%)

Interest expense

1.3k5.6k

Interest income

2.0k668.02.7k60.4k126.8k110.7k

Pre tax profit

(3.4m)(9.1m)

Net Income

(3.4m)(9.1m)(20.5m)(18.2m)(24.6m)(33.0m)

CorMedix Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

835.5k2.4m4.3m11.8m8.1m10.4m

Accounts Receivable

Inventories

80.0k376.6k166.7k594.2k

Current Assets

1.1m2.9m5.0m37.1m21.8m13.3m

PP&E

4.7k36.1k41.5k37.9k69.7k186.3k

Total Assets

1.2m3.0m5.1m37.1m21.9m13.5m

Accounts Payable

928.6k939.8k893.4k1.7m1.6m1.8m

Short-term debt

Current Liabilities

1.5m1.7m1.4m3.1m4.1m6.3m

Long-term debt

Total Debt

Total Liabilities

1.5m7.0m3.1m4.1m6.3m

Additional Paid-in Capital

45.9m51.7m79.7m128.3m136.9m159.2m

Retained Earnings

(76.2m)(94.4m)(119.2m)(152.2m)

Total Equity

(335.4k)(4.0m)3.6m34.0m17.8m7.2m

Financial Leverage

-3.4 x-0.7 x1.4 x1.1 x1.2 x1.9 x

CorMedix Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(3.4m)(9.1m)(20.5m)(18.2m)(24.6m)(33.0m)

Depreciation and Amortization

7.0k5.2k15.1k25.6k36.9k

Accounts Receivable

Inventories

(80.0k)(38.5k)79.8k(100.5k)

Accounts Payable

(15.7k)10.6k893.4k825.1k(63.6k)157.5k

Cash From Operating Activities

(2.3m)(3.6m)(12.5m)(22.3m)(28.6m)

Purchases of PP&E

(35.7k)(15.4k)(58.7k)(152.0k)

Cash From Investing Activities

(35.7k)(23.6m)11.4m10.4m

Cash From Financing Activities

1.1m5.2m43.6m7.1m20.5m

Interest Paid

118.1k4.0k1.2k5.6k

CorMedix Ratios

USDY, 2018

Financial Leverage

-0.8 x
Report incorrect company information

CorMedix Employee Rating

0 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source